Atnaujinkite slapukų nuostatas

El. knyga: Vaccine Safety Research, Data Access, and Public Trust

  • Formatas: 152 pages
  • Išleidimo metai: 29-Apr-2005
  • Leidėjas: National Academies Press
  • Kalba: eng
  • ISBN-13: 9780309548748
Kitos knygos pagal šią temą:
  • Formatas: 152 pages
  • Išleidimo metai: 29-Apr-2005
  • Leidėjas: National Academies Press
  • Kalba: eng
  • ISBN-13: 9780309548748
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

The Vaccine Safety Datalink (VSD) is a large, linked database of patient information that was developed jointly by CDC and several private managed care organizations in 1991. It includes data on vaccination histories, health outcomes, and characteristics of more than 7 million patients of eight participating health organizations. Researchers from CDC and the managed care groups have used VSD information to study whether health problems are associated with vaccinations. The subsequent VSD data sharing program was launched in 2002 to allow independent, external researchers access to information in the database.

In this report, the committee that was asked to review aspects of this program recommends that two new oversight groups are needed to ensure that the policies and procedures of the VSD and its data sharing program are implemented as fairly and openly as possible.



Table of Contents



Front Matter Executive Summary 1 Study Background and Contextual Issues 2 Description of the Vaccine Safety Datalink 3 The Vaccine Safety Datalink Data Sharing Program 4 The Vaccine Safety Datalink Research Process and the Release of Preliminary Findings 5 Independent Review of Vaccine Safety Datalink Activities Concluding Remarks References Appendix A Committee Biographies Appendix B Glossary Appendix C Acronyms Appendix D Meeting OneAgenda Appendix E Meeting TwoAgenda Appendix F Summary of Public Submissions Appendix G Notice and Request for Comment on Procedures and Costs for Use of the Research Data Center
EXECUTIVE SUMMARY 1(13)
1 STUDY BACKGROUND AND CONTEXTUAL ISSUES 13
Charge to the Committee,
14(2)
Study Process,
16(1)
Context of This Study,
17(2)
Issues Framing the Committee's Deliberations,
19(1)
Previous Release of Preliminary Findings from the Vaccine Safety Datalink,
20(1)
How Trust Affects the Vaccine Safety Datalink,
21(2)
Overarching Principles,
23(2)
2 DESCRIPTION OF THE VACCINE SAFETY DATALINK 25(8)
Role of FDA and CDC in Assessing Vaccine Safety,
25(3)
Development of the Vaccine Safety Datalink,
28(1)
Complexity and Limitations of the Vaccine Safety Datalink Database,
29(2)
The Shelby Amendment and the Information Quality Act,
31(2)
3 THE VACCINE SAFETY DATALINK DATA SHARING PROGRAM 33(43)
Design and Implementation to Date of the Vaccine Safety Datalink Data Sharing Program,
33(2)
The Vaccine Safety Datalink Data Sharing Program's Ability to Share Data,
35(2)
Current Standards of Practice of Similar Data Sharing Programs,
37(21)
Framework of Recommendations on Access to Vaccine Safety Datalink Data,
58(1)
Limitations of Data Available Through the Vaccine Safety Datalink Data Sharing Program,
59(6)
Specific Components of the Vaccine Safety Datalink Data Sharing Program Guidelines,
65(11)
4 THE VACCINE SAFETY DATALINK RESEARCH PROCESS AND THE RELEASE OF PRELIMINARY FINDINGS 76(20)
Review of Iterative Analysis Approaches Used for Vaccine Safety Datalink Studies,
76(4)
Vaccine Safety Datalink Research Plan,
80(3)
Sharing Vaccine Safety Datalink Program Information,
83(2)
The Role of Peer Review,
85(2)
Release of Preliminary Findings,
87(9)
5 INDEPENDENT REVIEW OF VACCINE SAFETY DATALINK ACTIVITIES 96(8)
NVAC Subcommittee to Review and Provide Advice on the Vaccine Safety Datalink Research Plan,
97(2)
Independent Committee to Review Vaccine Safety Datalink Research Proposals and Provide Advice on the Release of Preliminary Findings,
99(5)
CONCLUDING REMARKS 104(1)
REFERENCES 105(6)
APPENDIXES
A Committee Biographies
111(4)
B Glossary
115(2)
C Acronyms
117(2)
D Meeting One-Agenda
119(4)
E Meeting Two-Agenda
123(4)
F Summary of Public Submissions
127(5)
G Notice and Request for Comment on Procedures and Costs for Use of the Research Data Center
132
Committee on the Review of the National Immunization Program's Research Procedures and Data Sharing Program